All In Biotech

Drug Trial Radar · NCT04800315

A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

A Phase 2, Multicenter, Global, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Cendakimab (CC-93538) in Adult Subjects With Moderate to Severe Atopic Dermatitis

Last checked: Nov 19, 2026Latest source record: Jan 3, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 221 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

221

Actual

Start

May 14, 2021

Primary completion

Jul 20, 2022

Study completion Nov 9, 2022

Sponsor

Lead sponsor
CelgeneBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Mar 16, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the effectiveness and safety of 3 dose regimen of CC-93538 in adult participants with moderate to severe Atopic Dermatitis (AD).

Conditions

  • Dermatitis, Atopic
  • Eczema

Interventions

  • CC-93538Drug

    Specified dosages on specified days

  • PlaceboOther

    Specified dosages on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Percentage Change From Baseline in EASI at Week 16Time frame: From initial EASI measurement to week 16

Locations

157 sites in 6 countries. Site status is shown where the registry gives one.

  • Clinical Research Center of Alabama

    Birmingham, Alabama

  • Local Institution - 119

    Birmingham, Alabama

  • Cahaba Dermatology

    Birmingham, Alabama

  • Local Institution - 114

    Birmingham, Alabama

  • Burke Pharmaceutical Research

    Hot Springs, Arkansas

  • Local Institution - 129

    Hot Springs, Arkansas

  • First OC Dermatology

    Fountain Valley, California

  • Local Institution - 105

    Fountain Valley, California

  • George Washington University School of Medicine and Health Sciences

    Washington D.C., District of Columbia

  • Local Institution - 128

    Washington D.C., District of Columbia

  • Total Vein and Skin, LLC

    Boynton Beach, Florida

  • Local Institution - 106

    Delray Beach, Florida

  • Palm Beach Dermatology Group

    Delray Beach, Florida

  • GCP Global Clinical Professionals

    St. Petersburg, Florida

  • Local Institution - 135

    St. Petersburg, Florida

  • ForCare Clinical Research

    Tampa, Florida

  • Local Institution - 101

    Tampa, Florida

  • Local Institution - 103

    West Palm Beach, Florida

  • Metabolic Research Institute Inc

    West Palm Beach, Florida

  • Aeroallergy Research Labs of Savannah

    Savannah, Georgia

  • Local Institution - 134

    Savannah, Georgia

  • Local Institution - 108

    Springfield, Illinois

  • Sneeze Wheeze and Itch Associates LLC

    Springfield, Illinois

  • DS Research

    Clarksville, Indiana

  • Local Institution - 115

    Clarksville, Indiana

  • Dawes Fretzin Clinical Research Group, LLC

    Indianapolis, Indiana

  • Local Institution - 110

    Indianapolis, Indiana

  • Local Institution - 107

    West Lafayette, Indiana

  • Randall Dermatology

    West Lafayette, Indiana

  • Local Institution - 138

    Westfield, Indiana

  • Randall Dermatology - Westfield Campus

    Westfield, Indiana

  • Kansas City Dermatology P.A.

    Overland Park, Kansas

  • Local Institution - 116

    Overland Park, Kansas

  • DS Research

    Louisville, Kentucky

  • Local Institution - 117

    Louisville, Kentucky

  • DermAssociates

    Silver Spring, Maryland

  • Local Institution - 125

    Silver Spring, Maryland

  • Local Institution - 133

    Clarkston, Michigan

  • Skin Research Clarkston/Clarkston Dermatology

    Clarkston, Michigan

  • Local Institution - 137

    Omaha, Nebraska

Showing 40 of 157 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.